Journal Information
Vol. 102. Issue 1.
Pages 28-38 (January - February 2011)
Share
Share
Download PDF
More article options
Vol. 102. Issue 1.
Pages 28-38 (January - February 2011)
Original article
Full text access
Design and Validation of a Questionnaire to Measure Treatment Satisfaction in Patients With Moderate-to-Severe Psoriasis: the NEODERMA Study
Diseño y validación de un cuestionario para medir la satisfacción con el tratamiento del paciente con psoriasis moderada y grave: estudio NEODERMA
Visits
6379
M. Riberaa,
Corresponding author
miquel.ribera@uab.cat

Corresponding author.
, E. Daudénb, L. Puigc, V. García-Patos Brionesd, J.M. Herranze, X. Bordasf, F. Vanaclochag, on behalf of the NEODERMA Study Group
a Servicio de Dermatología, Hospital Universitari de Sabadell, Corporació Parc Taulí, Sabadell, Barcelona, Spain
b Servicio de Dermatología, Hospital de la Princesa, Madrid, Spain
c Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
d Servicio de Dermatología, Hospital de la Vall d’Hebron, Barcelona, Spain
e Servicio de Dermatología, Hospital Infanta Leonor, Madrid, Spain
f Servicio de Dermatología, Hospital de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
g Servicio de Dermatología, Hospital 12 de Octubre, Madrid, Spain
This item has received
Article information
Abstract
Background and objectives

The aim of this study was to design and assess the validity, reliability, and sensitivity to change of the Spanish Satisfaction With Treatment of Psoriasis Questionnaire (SSTPQ) for use in patients with moderate-to-severe psoriasis.

Patients and methods: A prospective, multicenter, observational, naturalistic study was designed. The instrument consisted of 12 items scored on a 5-point Likert scale with scores from 0 (very satisfied) to 5 (very unsatisfied), generating a total score of 0 to 48. Patients completed the questionnaire at baseline and then at 3-, 6-, 9-, and 12-month follow-up. At each visit, data were also collected on the Psoriasis Area and Severity Index (PASI), treatment adherence (Morisky-Green questionnaire), and overall treatment satisfaction on a Visual Analogue Scale (VAS) from 0 to 100.

Results

A total of 423 patients were included in the study and 68% completed 12 months of follow-up. Responses were provided to all items in 98.8% of cases. There was a weak correlation between changes in treatment satisfaction on the SSTPQ and changes in PASI score (r=0.38 to 0.33); in contrast, there were strong correlations with changes in the VAS score for overall treatment satisfaction (r=–0.75 to –0.81). Good internal consistency was observed (Cronbach α=0.92). The intraclass correlation coefficient was 0.89, with a mean difference in score at 3- and 6-month follow-up of 0.07.

Conclusions

The results obtained suggest that the SSTPQ is a feasible, valid, and reliable tool for the assessment of treatment satisfaction in patients with moderate-to-severe psoriasis.

Keywords:
Satisfaction questionnaire
Treatment
Psoriasis
Validity
Reliability
Spanish Satisfaction With Treatment of Psoriasis Questionnaire (SSTPQ)
Resumen
Introducción y objetivos

El objetivo del estudio fue diseñar y evaluar la validez, fiabilidad y sensibilidad al cambio de un cuestionario de satisfacción del tratamiento para el paciente con psoriasis moderada y grave, denominado CESTEP (Cuestionario Español de Satisfacción de Tratamiento en Psoriasis).

Pacientes y métodos

Se diseñó un estudio observacional, prospectivo, naturalístico y multicéntrico. El cuestionario estaba formado por 12 ítems, cada uno de los cuales se valoraba con una escala de tipo Likert con respuestas puntuables de 0 (muy satisfecho) a 5 (muy insatisfecho) (puntuación total de 0 a 48). Los pacientes cumplimentaron el cuestionario de satisfacción en la visita basal y a los 3, 6, 9 y 12 meses de seguimiento. En cada visita se recogieron también las variables clínicas (índice PASI), la adherencia con el tratamiento (cuestionario Morisky-Green) y la valoración global de la satisfacción con el tratamiento mediante una escala analógica visual (EAV) de 0 a 100.

Resultados

Se incluyeron un total de 423 pacientes, de los cuales el 68% finalizaron los 12 meses de seguimiento. El 98,8% de los pacientes completaron todas las preguntas del cuestionario. Los cambios en el cuestionario de satisfacción y en el índice PASI durante el estudio se correlacionaron de manera baja (r de 0,38 a 0,33), pero se observaron, en cambio, correlaciones altas con los cambios en la EAV de satisfacción (r de −0,75 a −0,81). Se obtuvo una buena consistencia interna (α de Cronbach de 0,92). El coeficiente de correlación intraclase era de 0,89, con una diferencia media en las puntuaciones, entre la visita a los 3 meses y a los 6 meses de 0,07 puntos.

Conclusiones

Los resultados obtenidos indican que el cuestionario CESTEP para la evaluación de la satisfacción del tratamiento en pacientes con psoriasis moderada y grave puede ser utilizado para tal finalidad, ya que se ha mostrado factible, válido y fiable.

Palabras clave:
Cuestionario de satisfacción
Tratamiento
Psoriasis
Validez
Fiabilidad
CESTEP
Full text is only aviable in PDF
References
[1.]
G. Krueger, J. Koo, M. Lebwohl, A. Menter, R.S. Stern, T. Rolstad.
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.
Arch Dermatol, 137 (2001), pp. 280-284
[2.]
M. Ribera, G. Caballé, N. Fernández-Chico, M.J. Fuente, C. Ferrándiz.
Impacto de la psoriasis en la calidad de vida del paciente español.
Piel, 19 (2004), pp. 243-249
[3.]
J. Garduno, M.J. Bhosle, R. Balkrishnan, S.R. Feldman.
Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review.
J Dermatolog Treat, 18 (2007), pp. 223-242
[4.]
J. de Korte, M.A. Sprangers, F.M. Mombers, J.D. Bos.
Quality of life in patients with psoriasis: a systematic literature review.
J Investig Dermatol Symp Proc, 9 (2004), pp. 140-147
[5.]
H. Both, M.L. Essink-Bot, J. Busschbach, T. Nijsten.
Critical review of generic and dermatology-specific health-related quality of life instruments.
Invest Dermatol, 127 (2007), pp. 2726-2739
[6.]
T. Fredriksson, U. Pettersson.
Severe psoriasis–oral therapy with a new retinoid.
Dermatologica, 157 (1978), pp. 238-244
[7.]
A.Y. Finlay, G.K. Khan.
Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use.
Clin Exp Dermatol, 19 (1994), pp. 210-216
[8.]
J. De Korte, F.M. Mombers, M.A. Sprangers, J.D. Bos.
The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review.
Arch Dermatol, 138 (2002), pp. 1221-1227
[9.]
J. Koo, C.M. Kozma, K. Reinke.
The development of a disease-specific questionnaire to assess quality of life for psoriasis patients: an analysis of the reliability, validity, and responsiveness of the Psoriasis Quality of Life Questionnaire.
Dermatol Psychosom, 3 (2002), pp. 171-179
[10.]
S.P. Mckenna, S.A. Cook, D. Whalley, L.C. Doward, H.L. Richards, C.E.M. Griffiths, et al.
Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials.
Br J Dermatol, 149 (2003), pp. 323-331
[11.]
A.P. Townshend, C.M. Chen, H.C. Williams.
How prominent are patient-reported outcomes in clinical trials of dermatological treatments?.
Br J Dermatol, 159 (2008), pp. 1152-1159
[12.]
H. Morsy, S. Kamp, G.B. Jemec.
Outcomes in randomized controlled trials in psoriasis: what has changed over the last 20 years?.
J Dermatolog Treat, 18 (2007), pp. 261-267
[13.]
D.A. Revicki.
Patient assessment of treatment satisfaction: methods and practical issues.
Gut, 53 (2004), pp. iv40-iv44
[14.]
C.C. Thiedke.
What do we really know about patient satisfaction?.
Fam Pract Manag, 14 (2007), pp. 33-36
[15.]
T.V. Perneger.
Adjustment for patient characteristics in satisfaction surveys.
Int J Qual Health Care, 16 (2004), pp. 433-435
[16.]
R. Powell.
Measuring patient satisfaction.
Br J Gen Pract, 58 (2008), pp. 50-51
[17.]
J. Sitzia.
How valid and reliable are patient satisfaction data? An analysis of 195 studies.
Int J Qual Health Care, 11 (1999), pp. 319-328
[18.]
R. Kravitz.
Patient satisfaction with health care: critical outcome or trivial pursuit?.
J Gen Intern Med, 13 (1998), pp. 280-282
[19.]
A.Y. Finlay, J.P. Ortonne.
Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy.
J Cutan Med Surg, 8 (2004), pp. 310-320
[20.]
M. Abe, H. Ishibuchi, T. Syuto, Y. Sogabe, Y. Yokoyama, O. Ishikawa.
Clinical usefulness and patient satisfaction for treatment with low-dose cyclosporin administration in patients with moderate psoriasis vulgaris.
J Dermatol, 34 (2007), pp. 290-293
[21.]
D.H. Ciocon, E.J. Horn, A.B. Kimball.
Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only: results of the 2005 Spring US National Psoriasis Foundation Survey.
Am J Clin Dermatol, 9 (2008), pp. 111-117
[22.]
N. Hidemi, I. Atsuyuki, E. Takafumi, O. Akira, N. Osamu.
The results of a psoriasis patients’ satisfaction survey (second report): analysis of factors contributing to overall satisfaction.
Japan J Dermatol, 115 (2005), pp. 1449-1459
[23.]
S.E. Althof, E.W. Corty, S.B. Levine, F. Levine, A.L. Burnett, K. McVary, et al.
EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction.
Urology, 53 (1999), pp. 793-799
[24.]
J.M.C. Axon, E. Treasure, E.C. Huskisson, D.L. Scott.
A novel index for measuring patients’ satisfaction.
Br J Rheumatol, 29 (1990), pp. 80
[25.]
K.S. Lewis, C. Bradley, G. Knight, A.J. Boulton, J.D. Ward.
A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes.
Diabet Med, 5 (1988), pp. 235-242
[26.]
A.Y. Finlay, G.K. Khan, D.K. Luscombe, M.S. Salek.
Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis.
Br J Dermatol, 123 (1990), pp. 751-756
[27.]
A.G. de Tiedra, J. Mercadal, X. Badía, J.M. Mascaró, M. Herdman, R. Lozano.
Adaptación transcultural al español del cuestionario Dermatology Life Quality Index (DLQI): El Índice de Calidad de Vida en Dermatología.
Actas Dermosifilogr, 89 (1998), pp. 692-700
[28.]
D.E. Morisky, L.W. Green, D.M. Levine.
Concurrent and predictive validity of a self-reported measure of medication adherence.
Med Care, 24 (1986), pp. 67-74

See Appendix 1 for a list of the members of the NEODERMA Study Group.

Copyright © 2011. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?